Personalis Reports First Quarter Results and Recent Highlights

Clinical test volume surged 258% year-over-year and 26% sequentially to 7,815 tests in Q1 M edicare coverage secured for lung cancer surveillance, providing a clear path to monetize rapidly growing clinical test volumes FREMONT, Calif. --(BUSINESS WIRE)--May 7, 2026-- Personalis, Inc.